1. Signaling Pathways
  2. PI3K/Akt/mTOR
  3. mTOR

mTOR (哺乳动物雷帕霉素靶蛋白)

Mammalian target of Rapamycin

mTOR(哺乳动物雷帕霉素靶蛋白)是一种由人类 mTOR 基因编码的蛋白质。mTOR 是一种丝氨酸/苏氨酸蛋白激酶,可调节细胞生长、细胞增殖、细胞运动、细胞存活、蛋白质合成和转录。mTOR 属于磷脂酰肌醇 3-激酶相关激酶蛋白家族。mTOR 整合上游通路的输入,包括生长因子和氨基酸。mTOR 还能感知细胞营养、氧气和能量水平。mTOR 通路在人类疾病中失调,例如糖尿病、肥胖症、抑郁症和某些癌症。雷帕霉素通过与其细胞内受体 FKBP12 结合来抑制 mTOR。FKBP12-雷帕霉素复合物直接与 mTOR 的 FKBP12-雷帕霉素结合 (FRB) 域结合,从而抑制其活性。

mTOR (mammalian target of Rapamycin) is a protein that in humans is encoded by the mTOR gene. mTOR is a serine/threonine protein kinase that regulates cell growth, cell proliferation, cell motility, cell survival, protein synthesis, and transcription. mTOR belongs to the phosphatidylinositol 3-kinase-related kinase protein family. mTOR integrates the input from upstream pathways, including growth factors and amino acids. mTOR also senses cellular nutrient, oxygen, and energy levels. The mTOR pathway is dysregulated in human diseases, such as diabetes, obesity, depression, and certain cancers. Rapamycin inhibits mTOR by associating with its intracellular receptor FKBP12. The FKBP12-rapamycin complex binds directly to the FKBP12-Rapamycin Binding (FRB) domain of mTOR, inhibiting its activity.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-150061
    NVP-BBD130 Inhibitor
    NVP-BBD130 是一种有效的、稳定的、ATP 竞争性的、具有口服活性的 PI3KmTOR 抑制剂。
    NVP-BBD130
  • HY-N0656AR
    (+)-Usnic acid (Standard)

    (+)-地衣酸 (Standard)

    Inhibitor
    (+)-Usnic acid (Standard) 是 (+)-Usnic acid 的分析标准品。本产品用于研究及分析应用。(+)-Usnic acid 为地衣中的有效成分,可结合 mTOR 的 ATP 结合口袋,抑制 mTORC1/2 的活性。(+)-Usnic acid 可抑制 mTOR 下游效应蛋白 Akt (Ser473),4EBP1 和 S6K 的磷酸化水平,诱导自噬 (autophay),具有抗肿瘤活性。(+)-Usnic acid 对许多浮游革兰氏阳性细菌具有抗菌活性,包括金黄色葡萄球菌、粪肠球菌和粪肠球菌。
    (+)-Usnic acid (Standard)
  • HY-169100
    Antiproliferative agent-57
    Antiproliferative agent-57 (compound M2) 是一种肿瘤血管生成抑制剂。Antiproliferative agent-57 在缺氧条件下抑制 SiHa 细胞中 VEGF 分泌的能力 (IC50=0.68 μM),而不诱导细胞毒性。Antiproliferative agent-57 可调节肿瘤细胞中 PI3K/AKT/mTORMAPK 信号通路,来抑制肿瘤组织中 HIF-1αVEGF 的表达。
    Antiproliferative agent-57
  • HY-155376
    mTOR inhibitor-14 Inhibitor
    mTOR inhibitor-14 (compound 14c) 是一种有效的 mTOR抑制剂。mTOR inhibitor-14 还表现出较小的CYP2C8抑制作用。mTOR inhibitor-14 可以抑制肿瘤生长。
    mTOR inhibitor-14
  • HY-N0112R
    Dihydromyricetin (Standard)

    二氢杨梅素 (Standard)

    Inhibitor
    Dihydromyricetin (Standard) 是 Dihydromyricetin 的分析标准品。本产品用于研究及分析应用。Dihydromyricetin 是一种有效的二氢嘧啶酶 (dihydropyrimidinase) 抑制剂,IC50 为 48 μM。Dihydromyricetin 可通过抑制 mTOR 信号从而激活自噬。Dihydromyricetin 抑制 mTOR 复合体 (mTORC1/2) 形成。Dihydromyricetin 还是一种流感依赖 RNA 的 RNA 聚合酶抑制剂,IC50 为 22 μM。
    Dihydromyricetin (Standard)
  • HY-P10833
    C-VGB3 Inhibitor
    C-VGB3 是一种选择性血管内皮生长因子受体 2 (VEGFR2) 拮抗剂,可抑制 VEGFR2 介导的 PI3K/AKT/mTOR 和 PLCγ/ERK1/2 信号通路。C-VGB3 结合到 VEGFR2 的胞外结构域,阻断配体-受体相互作用,并通过内源性 (涉及 Bcl2 家族和半胱天冬酶) 和外源性 (死亡受体介导) 途径诱导内皮细胞和肿瘤细胞凋亡 (apoptosis)。C-VGB3 有望用于血管生成相关癌症的研究,如乳腺癌。
    C-VGB3
  • HY-RS08811
    Mtor Mouse Pre-designed siRNA Set A Inhibitor
    Mtor Mouse Pre-designed siRNA Set A 包括针对 Mtor (Mouse) 基因的不同区域设计三对 siRNA,以及阴性对照、FAM 标记阴性对照和阳性对照。
    Mtor Mouse Pre-designed siRNA Set A
    Mtor Mouse Pre-designed siRNA Set A
  • HY-N10754
    Aschantin Inhibitor
    Aschantin 是一种双环氧木脂素,可以从木兰中分离出来。Aschantin 具有抗疟原虫、Ca2+ 拮抗、血小板活化因子拮抗和化疗活性。 Aschantin 是一种 mTOR 激酶抑制剂。 Aschantin 也是细胞色素 P450UGT 酶的抑制剂。
    Aschantin
  • HY-176435
    mTOR inhibitor-28 Inhibitor
    mTOR inhibitor-28 (SM-3) 是一种有效的 mTOR 抑制剂。mTOR inhibitor-28 对 A549、H292 和 H460 细胞有抑制作用,IC50 分别为 72.74、67.66 和 43.24 μM。
    mTOR inhibitor-28
  • HY-160548
    mTOR inhibitor-18 Inhibitor
    mTOR inhibitor-18 (Example 106) 是一种 mTOR 抑制剂。mTOR inhibitor-18 可用于 mTOR 相关研究,如癌症、免疫疾病、心血管疾病、病毒感染、炎症、代谢/内分泌功能障碍和神经系统疾病。
    mTOR inhibitor-18
  • HY-15281
    QL-IX-55 Inhibitor
    QL-IX-55 是 ATP 竞争性 mTORC1/2 抑制剂,对人 mTORC1,酵母 mTORC1 和 2 的 IC50 分别为 50,50 和 10-50 nM。
    QL-IX-55
  • HY-RS08812
    Mtor Rat Pre-designed siRNA Set A Inhibitor
    Mtor Rat Pre-designed siRNA Set A 包括针对 Mtor (Rat) 基因的不同区域设计三对 siRNA,以及阴性对照、FAM 标记阴性对照和阳性对照。
    Mtor Rat Pre-designed siRNA Set A
    Mtor Rat Pre-designed siRNA Set A
  • HY-15901
    LGB321 Inhibitor
    LGB321 是针对 PIM2 依赖性多发性骨髓瘤细胞系抑制剂,有效抑制增殖和关键信号通路(如 mTOR-C1)以及 BAD 的磷酸化。
    LGB321
  • HY-170405
    YB-3–17 Inhibitor
    YB-3-17 是一种双功能分子,可抑制 mTORIC50=0.22 nM)或通过 PROTAC 机制降解 G1 至 S 期转变 1 基因(GSPT1DC50=5 nM)。YB-3-17 在多种胶质母细胞瘤细胞系中表现出抗增殖活性,IC50 为纳摩尔水平。YB-3-17 在小鼠模型中表现出抗肿瘤活性。(Pink: ligand for target protein (HY-170407); Black: linker (HY-A0102); Blue: ligand for E3 ligase Cereblon (HY-14658))
    YB-3–17
  • HY-N6602R
    α-Solanine (Standard)

    α-茄碱 (Standard)

    Inhibitor
    α-Solanine (Standard) 是 α-Solanine 的分析标准品。本产品用于研究及分析应用。α-solanine 是Solanum nigrum中的一种生物活性成分,是主要的甾体类生物碱之一,可抑制癌细胞的生长并诱导其凋亡 (apoptosis)。
    α-Solanine (Standard)
  • HY-141476
    PI3K/mTOR Inhibitor-3 Inhibitor
    PI3K/mTOR Inhibitor-3 (化合物 12) 是一种咪唑并喹啉类化合物,是有效的 PI3KmTOR 双重抑制剂。PI3K/mTOR Inhibitor-3 具有抗癌活性。
    PI3K/mTOR Inhibitor-3
  • HY-W742805
    Sulindac Sulfone-d6
    Sulindac Sulfone-d6 是 Sulindac sulfone (HY-B1787) 的氘代物。Sulindac sulfone 是一种 mTORC1 通路抑制剂,也是 Sulindac 的代谢产物。Sulindac sulfone 可抑制结肠癌细胞生长并诱导细胞周期停滞。Sulindac sulfone 可用于癌症的研究。
    Sulindac Sulfone-</sub>d<sub>6</sub>
  • HY-162147
    Nur77 modulator 3 Inhibitor 99.01%
    Nur77 modulator 3 (9e) 可以与 Nur77 结合,并以 Nur77 依赖的方式抑制 TGF-β1 诱导的 α-SMA 和 COLA1 的表达。Nur77 modulator 3 在体外和体内通过抑制 mTORC1 信号通路诱导 Nur77 表达并增强自噬通量。Nur77 modulator 3 阻断肝纤维化的进展。
    Nur77 modulator 3
  • HY-N0486S13
    L-Leucine-15N,d10

    L-亮氨酸-15N,d10

    L-Leucine-15N,d10 是一种必需的支链氨基酸 (BCAA),可激活 mTOR 信号通路。
    L-Leucine-<sup>15</sup>N,d<sub>10</sub>
  • HY-176166
    PD-M6 Degrader
    PD-M6 是一种 mTOR PROTAC 降解剂 (DC50: 4.8 μM)。PD-M6 能促进 mTOR 的泛素化和降解。PD-M6 可抑制 HeLa、MCF-7 和 HepG2 癌细胞系的增殖 (IC50 值分别为 11.3、2.58 和 3.23 μM) 并诱导自噬。PD-M6 可特异性诱导 mTOR 信号通路中的关键蛋白 LAMTOR1 的降解。(粉色:靶蛋白 mTOR 配体 (HY-B0795);靶蛋白 mTOR 配体的活性对照 (HY-W150930);黑色:连接子 (HY-W008296);蓝色:E3连接酶 CRBN 配体 (HY-41547);靶蛋白配体的活性对照+连接子 (HY-176167))。
    PD-M6
目录号 产品名 / 同用名 应用 反应物种

The mammalian target of rapamycin (mTOR) signaling pathway integrates both intracellular and extracellular signals and serves as a central regulator of cell metabolism, growth, proliferation and survival[1]. mTOR is the catalytic subunit of two distinct complexes called mTORC1 and mTORC2. mTORC1 comprises DEPTOR, PRAS40, RAPTOR, mLST8, mTOR, whereas mTORC2 comprises DEPTOR, mLST8, PROTOR, RICTOR, mSIN1, mTOR[2]. Rapamycin binds to FKBP12 and inhibits mTORC1 by disrupting the interaction between mTOR and RAPTOR. mTORC1 negatively regulates autophagy through multiple inputs, including inhibitory phosphorylation of ULK1 and TFEB. mTORC1 promotes protein synthesis through activation of the translation initiation promoter S6K and through inhibition of the inhibitory mRNA cap binding 4E-BP1, and regulates glycolysis through HIF-1α. It promotes de novo lipid synthesis through the SREBP transcription factors. mTORC2 inhibits FOXO1,3 through SGK and Akt, which can lead to increased longevity. The complex also regulates actin cytoskeleton assembly through PKC and Rho kinase[3]

 

Growth factors: Growth factors can signal to mTORC1 through both PI3K-Akt and Ras-Raf-MEK-ERK axis. For example, ERK and RSK phosphorylate TSC2, and inhibit it.

 

Insulin Receptor: The activated insulin receptor recruits intracellular adaptor protein IRS1. Phosphorylation of these proteins on tyrosine residues by the insulin receptor initiates the recruitment and activation of PI3K. PIP3 acts as a second messenger which promotes the phosphorylation of Akt and triggers the Akt-dependent multisite phosphorylation of TSC2. TSC is a heterotrimeric complex comprised of TSC1, TSC2, and TBC1D7, and functions as a GTPase activating protein (GAP) for the small GTPase Rheb, which directly binds and activates mTORC1. mTORC2 primarily functions as an effector of insulin/PI3K signaling. 

 

Wnt: The Wnt pathway activates mTORC1. Glycogen synthase kinase 3β (GSK-3β) acts as a negative regulator of mTORC1 by phosphorylating TSC2. mTORC2 is activated by Wnt in a manner dependent on the small GTPase RAC1[4].

 

Amino acids: mTORC1 senses both lysosomal and cytosolic amino acids through distinct mechanisms. Amino acids induce the movement of mTORC1 to lysosomal membranes, where the Rag proteins reside. A complex named Ragulator, interact with the Rag GTPases, recruits them to lysosomes through a mechanism dependent on the lysosomal v-ATPase, and is essential for mTORC1 activation. In turn, lysosomal recruitment enables mTORC1 to interact with GTP-bound RHEB, the end point of growth factor. Cytosolic leucine and arginine signal to mTORC1 through a distinct pathway comprised of the GATOR1 and GATOR2 complexes.    

 

Stresses: mTORC1 responds to intracellular and environmental stresses that are incompatible with growth such as low ATP levels, hypoxia, or DNA damage. A reduction in cellular energy charge, for example during glucose deprivation, activates the stress responsive metabolic regulator AMPK, which inhibits mTORC1 both indirectly, through phosphorylation and activation of TSC2, as well as directly through the phosphorylation of RAPTOR. Sestrin1/2 are two transcriptional targets of p53 that are implicated in the DNA damage response, and they potently activate AMPK, thus mediating the p53-dependent suppression of mTOR activity upon DNA damage. During hypoxia, mitochondrial respiration is impaired, leading to low ATP levels and activation of AMPK. Hypoxia also affects mTORC1 in AMPK-independent ways by inducing the expression of REDD1, the protein products of which then suppress mTORC1 by promoting the assembly of TSC1-TSC2[2].

 

Reference:

[1]. Laplante M, et al.mTOR signaling at a glance.J Cell Sci. 2009 Oct 15;122(Pt 20):3589-94. 
[2]. Zoncu R, et al. mTOR: from growth signal integration to cancer, diabetes and ageing.Nat Rev Mol Cell Biol. 2011 Jan;12(1):21-35. 
[3]. Johnson SC, et al. mTOR is a key modulator of ageing and age-related disease.Nature. 2013 Jan 17;493(7432):338-45.
[4]. Shimobayashi M, et al. Making new contacts: the mTOR network in metabolism and signalling crosstalk.Nat Rev Mol Cell Biol. 2014 Mar;15(3):155-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.